2015 Annual SIOPEL Spring Meeting

The next SIOPEL group spring meeting will take place in Oslo, Norway, 24-25 April 2015. Attached you will find the details and the booking forms to register.







E-Learning area

We would like to inform that our E-Learning area is open and accessible by all health care providers (whether SIOPEL members or not) interested in the subject of pediatric liver tumors. In order to get access please send an email to using your institutional email address.

Papers Recently Published

We proudly announce that important papers under the frame of the CHIC initiative have been published:

a. López-Terrada D et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium.Mod Pathol. 2014 Mar;27(3):472-91

b. Czauderna P et al. Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy.Curr Opin Pediatr. 2014 Feb;26(1):19-28

c. Meyers RL et al. Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation.Curr Opin Pediatr. 2014 Feb;26(1):29-36


Childhood Liver Tumours Strategy Group - SIOPEL

The ultimate goal of the SIOPEL study group is to improve the prognosis and the quality of life of children affected by primary childhood liver tumors.

Primary hepatic tumours represent less than 1% of all childhood malignancies. Their frequency according to the different series is of about 0.8 - 1 case per million children less than 15 years of age per year. Hepatoblastoma (HB) is by far the commonest histological subtype of primary malignant hepatic tumours occurring in children less than 15 years of age, followed by hepatocellular carcinoma (HCC).

SIOPEL Group is composed of basic and clinical scientists coming from different European and Extra-European countries.